Zhitong Financial App News, TATA Health (01255) announced interim results for 2023, with revenue of about HK $104 million, up 63.9% from the same period last year. The loss attributable to the owners of the company was HK $12.327 million, compared with a profit of HK $20.169 million for the same period last year; a loss of HK $0.050 per share.
Of this total, revenue from the footwear business was about HK $101 million, up about 62.5 per cent from a year earlier. During the reporting period, the group achieved an increase of about 54.3% in same-store sales.
The loss was mainly due to medical expenses in the footwear business and an increase in the remuneration of directors, the notice said.